PCSB Financial Corp

$ Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000156459021054913 Filed on November 05, 2021

Income Statement

Concept	2021 Q3	2020 Q3

Balance Sheet

Concept	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$571.5M
YoY Change
Cash & Equivalents	$148.0M
Short-Term Investments	$423.5M	$318.5M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$20.50M	$20.20M
YoY Change	1.49%	-15.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.500M	$3.400M
YoY Change	-26.47%	47.83%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.873B	$1.791B
YoY Change	4.58%	7.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$9.500M	$10.80M
YoY Change	-12.04%	-14.29%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.500M	$10.80M
YoY Change	-12.04%	-14.29%
LONG-TERM LIABILITIES
Long-Term Debt	$6.800M	$6.400M
YoY Change	6.25%	-15.79%
Other Long-Term Liabilities	$11.60M	$17.10M
YoY Change	-32.16%	44.92%
Total Long-Term Liabilities	$18.40M	$23.50M
YoY Change	-21.7%	21.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.500M	$10.80M
Total Long-Term Liabilities	$18.40M	$23.50M
Total Liabilities	$1.599B	$1.517B
YoY Change	5.34%	10.19%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$274.7M	$273.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.873B	$1.791B
YoY Change	4.58%	7.99%

Cashflow Statement

Concept	2021 Q3	2020 Q3

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M6D
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M6D
CY2021Q3	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-105000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	187000
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3509000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2915000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	274560000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	3614000
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.06
CY2021Q3	us-gaap	Dividends Common Stock DividendsCommonStock	876000
CY2021Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3720000
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	810000
CY2021Q3	pcsb	Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares During Period EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedSharesDuringPeriod	24419
CY2021Q3	us-gaap	Amortization Of Esop Award AmortizationOfESOPAward	446000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	274728000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	273713000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2728000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	187000
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04
CY2020Q3	us-gaap	Dividends Common Stock DividendsCommonStock	630000
CY2020Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3449000
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	829000
CY2020Q3	pcsb	Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares During Period EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedSharesDuringPeriod	24419
CY2020Q3	us-gaap	Amortization Of Esop Award AmortizationOfESOPAward	301000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	273679000
CY2021Q3	us-gaap	Profit Loss ProfitLoss	3614000
CY2020Q3	us-gaap	Profit Loss ProfitLoss	2728000
CY2021Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	13000
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	109000
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	738000
CY2021Q3	pcsb	Amortization Of Premiums And Deferred Loan Costs AmortizationOfPremiumsAndDeferredLoanCosts	20000
CY2021Q3	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	152000
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	810000
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	829000
CY2021Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	446000
CY2020Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	301000
CY2021Q3	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	192000
CY2021Q3	pcsb	Accretion Of Purchase Accounting Adjustments AccretionOfPurchaseAccountingAdjustments	35000
CY2021Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1080000
CY2021Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3720000
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4182000
CY2020Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1879000
CY2021Q3	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	75504000
CY2020Q3	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	17289000
CY2021Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	12134000
CY2020Q3	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	6202000
CY2020Q3	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-33088000
CY2021Q3	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-1000
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	159000
CY2021Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20092000
CY2020Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	28616000
CY2021Q3	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	12955000
CY2020Q3	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	3757000
CY2021Q3	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	33000
CY2020Q3	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	33000
CY2021Q3	pcsb	Net Increase Decrease In Mortgage Escrow Funds NetIncreaseDecreaseInMortgageEscrowFunds	-3708000
CY2020Q3	pcsb	Net Increase Decrease In Mortgage Escrow Funds NetIncreaseDecreaseInMortgageEscrowFunds	-3703000
CY2021Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	876000
CY2020Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	630000
CY2021Q3	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1000
CY2020Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3449000
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4617000
CY2020Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4058000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11293000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26437000
CY2021Q3	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	148012000
CY2020Q3	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	162739000
CY2021Q3	us-gaap	Interest Paid Net InterestPaidNet	1694000
CY2020Q3	us-gaap	Interest Paid Net InterestPaidNet	2908000
CY2021Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	917000
CY2020Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2625000
CY2021Q3	pcsb	Number Of Subsidiaries NumberOfSubsidiaries	2
CY2021Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Use of Estimates</span>: To prepare financial statements in conformity with GAAP management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ. </p>
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	45028000
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	45015000
CY2021Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	378510000
CY2021Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	5664000
CY2021Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	2653000
CY2021Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	381521000
CY2021Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	57213000
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	557000
CY2021Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	383000
CY2021Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	57387000
CY2021Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	337584000
CY2021Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	5980000
CY2021Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	1427000
CY2021Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	342137000
CY2021Q3	pcsb	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	0
CY2020Q3	pcsb	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	0
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	2040000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	2052000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	3008000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	3026000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	44664000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	44809000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	5000000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5016000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount	37109000
CY2021Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	372000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	38392000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	10933000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	11015000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount	82087000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities After Ten Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue	81040000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	7041000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	6936000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount	212610000
CY2021Q3	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	215228000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	19046000
CY2021Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	19022000
CY2021Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	378510000
CY2021Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	381521000
CY2021Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	45028000
CY2021Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	45015000
CY2021Q3	us-gaap	Pledged Financial Instruments Not Separately Reported Securities Pledged PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged	162500000
CY2021Q2	us-gaap	Pledged Financial Instruments Not Separately Reported Securities Pledged PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged	180100000
CY2021Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	22951000
CY2021Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	466000
CY2021Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	1309000
CY2021Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	10000
CY2021Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	24260000
CY2021Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	476000
CY2021Q3	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	192287000
CY2021Q3	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	2574000
CY2021Q3	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	6273000
CY2021Q3	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	79000
CY2021Q3	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	198560000
CY2021Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	2653000
CY2021Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	27416000
CY2021Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	373000
CY2021Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	1339000
CY2021Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	10000
CY2021Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	383000
CY2021Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	134925000
CY2021Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1402000
CY2021Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	25000
CY2021Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	139900000
CY2021Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	1427000
CY2021Q3	us-gaap	Marketable Securities MarketableSecurities	423500000
CY2021Q3	pcsb	Number Of Securities Determined To Be Other Than Temporarily Impaired NumberOfSecuritiesDeterminedToBeOtherThanTemporarilyImpaired	0
CY2021Q2	pcsb	Number Of Securities Determined To Be Other Than Temporarily Impaired NumberOfSecuritiesDeterminedToBeOtherThanTemporarilyImpaired	0
CY2021Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1218833000
CY2021Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1237332000
CY2021Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	8159000
CY2021Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1210674000
CY2021Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1229451000
CY2021Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7881000
CY2021Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	13000
CY2021Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	107000
CY2021Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	8159000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	8639000
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	109000
CY2020Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	113000
CY2020Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	37000
CY2021Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	6561000
CY2021Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1210475000
CY2021Q3	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	1218757000
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	119000
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	8040000
CY2021Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	8159000
CY2021Q2	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	121000
CY2021Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7881000
CY2021Q3	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	6592000
CY2021Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	6561000
CY2021Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	119000
CY2021Q2	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	8258000
CY2021Q2	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	8059000
CY2021Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	7305000
CY2021Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	203000
CY2020Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	4628000
CY2020Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	60000
CY2021Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5311000
CY2021Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5354000
CY2021Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	421000
CY2021Q2	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	411000
CY2021Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	2071000
CY2021Q3	us-gaap	Loans And Leases Receivable Before Fees Gross LoansAndLeasesReceivableBeforeFeesGross	1218756000
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2681000
CY2021Q4	us-gaap	Loans And Leases Receivable Before Fees Gross LoansAndLeasesReceivableBeforeFeesGross	1237522000
CY2021Q3	pcsb	Financing Receivable Modifications Number Of Contracts Outstanding FinancingReceivableModificationsNumberOfContractsOutstanding	8
CY2021Q2	pcsb	Financing Receivable Modifications Number Of Contracts Outstanding FinancingReceivableModificationsNumberOfContractsOutstanding	12
CY2021Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	1600000
CY2021Q2	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	3100000
CY2021Q3	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	1200000
CY2021	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	2700000
CY2021Q3	pcsb	Financing Receivable Modifications Recorded Investment Of Specific Reserves To Customers FinancingReceivableModificationsRecordedInvestmentOfSpecificReservesToCustomers	119000
CY2021Q2	pcsb	Financing Receivable Modifications Recorded Investment Of Specific Reserves To Customers FinancingReceivableModificationsRecordedInvestmentOfSpecificReservesToCustomers	121000
CY2021Q3	pcsb	Commitment To Lend To Customers In Addition To Outstanding Loans Classified As Troubled Debt Restructurings CommitmentToLendToCustomersInAdditionToOutstandingLoansClassifiedAsTroubledDebtRestructurings	3000
CY2021Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2020Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2021Q3	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
CY2020Q3	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
CY2021Q3	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	993229
CY2021Q2	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	1017648
CY2021Q3	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	1436757
CY2021Q2	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	1435550
CY2021Q3	us-gaap	Employee Stock Ownership Plan Esop Deferred Shares Fair Value EmployeeStockOwnershipPlanESOPDeferredSharesFairValue	18315000
CY2021Q2	us-gaap	Employee Stock Ownership Plan Esop Deferred Shares Fair Value EmployeeStockOwnershipPlanESOPDeferredSharesFairValue	18491000
CY2021Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	446000
CY2020Q3	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	301000
CY2021Q3	pcsb	Fair Value Assets Transfers Between Levels FairValueAssetsTransfersBetweenLevels	0
CY2020Q3	pcsb	Fair Value Assets Transfers Between Levels FairValueAssetsTransfersBetweenLevels	0
CY2021Q3	pcsb	Capital Conservation Buffer Percentage At Beginning Stage CapitalConservationBufferPercentageAtBeginningStage	0.025
CY2021Q2	pcsb	Capital Conservation Buffer Percentage At Beginning Stage CapitalConservationBufferPercentageAtBeginningStage	0.025
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	3614000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2728000
CY2021Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15342975
CY2020Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	16404886
CY2021Q3	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	1005432
CY2020Q3	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	1102048
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14337543
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15302838
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	68273
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	111
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14405816
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15302949
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2021Q3	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	181815000
CY2021Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	182700000
CY2021Q3	us-gaap	Derivative Average Fixed Interest Rate DerivativeAverageFixedInterestRate	0.0254
CY2021Q2	us-gaap	Derivative Average Fixed Interest Rate DerivativeAverageFixedInterestRate	0.0255
CY2021Q3	us-gaap	Derivative Average Variable Interest Rate DerivativeAverageVariableInterestRate	0.0254
CY2021Q2	us-gaap	Derivative Average Variable Interest Rate DerivativeAverageVariableInterestRate	0.0255
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	329980
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.93
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1308963
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.00
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	35000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	12000
CY2021Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	17.66
CY2021Q3	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P8Y2M15D
CY2021	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P8Y5M15D
CY2021Q3	pcsb	Service Charges On Deposits ServiceChargesOnDeposits	183000
CY2020Q3	pcsb	Service Charges On Deposits ServiceChargesOnDeposits	162000
CY2021Q3	pcsb	Interchange Fees InterchangeFees	156000
CY2020Q3	pcsb	Interchange Fees InterchangeFees	131000
CY2021Q3	pcsb	Other Fees And Service Charges OtherFeesAndServiceCharges	62000
CY2020Q3	pcsb	Other Fees And Service Charges OtherFeesAndServiceCharges	29000
CY2021Q3	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	401000
CY2020Q3	us-gaap	Investment Banking Advisory Brokerage And Underwriting Fees And Commissions InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions	322000
CY2021Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	192000
CY2020Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	132000
CY2020Q3	pcsb	Swap Income SwapIncome	129000
CY2021Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	20000
CY2020Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	11000
CY2021Q3	us-gaap	Noninterest Income NoninterestIncome	613000
CY2020Q3	us-gaap	Noninterest Income NoninterestIncome	594000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	322580
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.95
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	8000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.66
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	600
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	12.34
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1320963
CY2021Q3	us-gaap	Loans And Leases Receivable Before Fees Gross LoansAndLeasesReceivableBeforeFeesGross	1218756000
CY2021Q2	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	130000
CY2020Q2	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	156000
CY2021Q3	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldAccretion	10000
CY2020Q3	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldAccretion	5000
CY2021Q3	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	120000
CY2020Q3	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	151000
CY2021Q3	pcsb	Defined Benefit Plan Effective Date Of Freezing And Termination DefinedBenefitPlanEffectiveDateOfFreezingAndTermination	2017-05-01
CY2021Q3	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0
CY2017Q2	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	1453209
CY2017Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2017Q2	pcsb	Employee Stock Ownership Plan Esop Payable Term EmployeeStockOwnershipPlanEsopPayableTerm	P15Y
CY2021Q3	pcsb	Employee Stock Ownership Plan Esop Prime Rate Percentage EmployeeStockOwnershipPlanEsopPrimeRatePercentage	0.0325
CY2021Q3	us-gaap	Employee Stock Ownership Plan Esop Debt Structure Direct Loan Amount EmployeeStockOwnershipPlanESOPDebtStructureDirectLoanAmount	10700000
CY2021Q3	us-gaap	Shares Held In Employee Stock Option Plan Committed To Be Released SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased	96881
CY2021Q3	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	443528
CY2021Q2	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	417902
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.98
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	119000
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	522385
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	19.01
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	37000
CY2021Q3	pcsb	Number Of Branch Offices Units In Real Estate Lease NumberOfBranchOfficesUnitsInRealEstateLease	11
CY2021Q3	pcsb	Number Of Administrative Office Units In Real Estate Lease NumberOfAdministrativeOfficeUnitsInRealEstateLease	1
CY2021Q3	pcsb	Lease Maturity Start Year LeaseMaturityStartYear	2022
CY2021Q3	pcsb	Lease Maturity End Year LeaseMaturityEndYear	2041
CY2021Q3	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	some of which include lessee options to extend the lease term.
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y6M29D
CY2021Q3	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The operating lease asset and lease liability are determined at the commencement date of the lease based on the present value of the lease payments.
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0239
CY2021Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0
CY2020Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0
CY2021Q3	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0
CY2020Q3	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	504000000000
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	504000000000
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9200000
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	9500000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1523000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1940000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1569000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1276000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	748000
CY2021Q3	pcsb	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	3802000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10858000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1384000
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	9474000

Files In Submission

Name	View Source	Status
0001564590-21-054913-index-headers.html	Edgar Link	pending
0001564590-21-054913-index.html	Edgar Link	pending
0001564590-21-054913.txt	Edgar Link	pending
0001564590-21-054913-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcsb-10q_20210930.htm	Edgar Link	pending
pcsb-10q_20210930_htm.xml	Edgar Link	completed
pcsb-20210930.xsd	Edgar Link	pending
pcsb-20210930_cal.xml	Edgar Link	unprocessable
pcsb-20210930_def.xml	Edgar Link	unprocessable
pcsb-20210930_lab.xml	Edgar Link	unprocessable
pcsb-20210930_pre.xml	Edgar Link	unprocessable
pcsb-ex101_394.htm	Edgar Link	pending
pcsb-ex311_6.htm	Edgar Link	pending
pcsb-ex312_7.htm	Edgar Link	pending
pcsb-ex32_8.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

PCSB Financial Corp

2021 Q3 Form 10-Q Financial Statement

#000156459021054913 Filed on November 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission